NeoGenomics, Inc.
NEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $661 | $592 | $510 | $484 |
| % Growth | 11.6% | 16.1% | 5.2% | – |
| Cost of Goods Sold | $370 | $347 | $322 | $297 |
| Gross Profit | $290 | $245 | $188 | $187 |
| % Margin | 43.9% | 41.3% | 36.9% | 38.6% |
| R&D Expenses | $31 | $27 | $30 | $22 |
| G&A Expenses | $226 | $209 | $211 | $221 |
| SG&A Expenses | $310 | $280 | $278 | $284 |
| Sales & Mktg Exp. | $85 | $71 | $67 | $63 |
| Other Operating Expenses | $41 | $45 | $37 | $0 |
| Operating Expenses | $382 | $352 | $346 | $306 |
| Operating Income | -$92 | -$108 | -$158 | -$119 |
| % Margin | -13.9% | -18.2% | -30.9% | -24.5% |
| Other Income/Exp. Net | $11 | $11 | -$2 | $104 |
| Pre-Tax Income | -$81 | -$97 | -$159 | -$15 |
| Tax Expense | -$2 | -$9 | -$15 | -$7 |
| Net Income | -$79 | -$88 | -$144 | -$8 |
| % Margin | -11.9% | -14.9% | -28.3% | -1.7% |
| EPS | -3.1 | -3.5 | -5.8 | -0.35 |
| % Growth | 11.4% | 39.7% | -1,557.1% | – |
| EPS Diluted | -3.1 | -3.5 | -5.8 | -0.35 |
| Weighted Avg Shares Out | 25 | 25 | 25 | 24 |
| Weighted Avg Shares Out Dil | 25 | 25 | 25 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18 | $17 | $6 | $3 |
| Interest Expense | $7 | $7 | $8 | $8 |
| Depreciation & Amortization | $73 | $73 | $69 | $53 |
| EBITDA | -$2 | -$18 | -$82 | -$65 |
| % Margin | -0.2% | -3% | -16.2% | -13.5% |